We are live on
!
Find out more
PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
187 hedge funds and large institutions have $387M invested in PDL BioPharma, Inc. in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 60 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 26
1% more funds holding
Funds holding: 186 → 187 (+1)
2% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 60
17% less capital invested
Capital invested by funds: $466M → $387M (-$79.7M)
52% less call options, than puts
Call options by funds: $186K | Put options by funds: $388K
Holders
187
Holders Change
+1
Holders Change %
+0.54%
% of All Funds
4.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
59
Reduced
60
Closed
26
Calls
$186K
Puts
$388K
Net Calls
-$202K
Net Calls Change
+$65K
Top Buyers
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.97M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$3.91M |
| 3 |
Renaissance Technologies
New York
|
-$2.6M |
| 4 |
Bank of New York Mellon
New York
|
-$2.48M |
| 5 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
-$1.96M |
